Clinical reviewer: Dr. Sarah Boss, MD

COGNIFUL publishes this guide and is part of THE BALANCE GROUP in Mallorca, Spain. Selected services below illustrate different care models, not an independent ranking of equivalent luxury centers. The comparison focuses on cannabis-specific needs, actual location, treatment methods, and suitability. Eligibility and availability must be checked with each provider. [1] [2]

Cannabis use disorder can involve difficulty controlling use, unsuccessful attempts to cut back, craving, and effects on responsibilities or relationships. The CDC describes these as clinically relevant features. An assessment should examine the person’s experience and functioning rather than decide from occupation, income, legal availability, or the image associated with a product. [3]

Tell the clinician about frequency, products, routes of use, known potency, and circumstances. Include prescribed medication, alcohol, tobacco, and other drugs. If the contents or strength are uncertain, say so. Product details can make the history more useful, but they do not replace an assessment of control, health, and daily functioning. [3] [1]

Ask what cannabis is currently being used for in your own routine. Is it linked to unwinding, sleep, distress, social situations, or a habit that has expanded over time? These are questions for assessment, not assumptions about the cause. A program should understand the role the person experiences before proposing how treatment will address it.

A person may continue working or fulfilling some responsibilities while still struggling with use. Equally, using cannabis does not automatically establish a disorder. The clinical task is to evaluate the pattern and consequences carefully. A provider should explain its reasoning rather than use either reassurance or alarm as a shortcut to a diagnosis.

If cannabis has been prescribed, involve the prescriber in any review. The underlying condition, intended benefit, adverse effects, and concerns about use all need consideration. Do not assume that every cannabis-related inquiry requires the same addiction pathway, or change prescribed treatment solely because an admissions package begins on a particular date.

Prepare information that makes assessment more useful

These are topics for a clinical conversation rather than a self-diagnostic scoring tool. A family member’s observations may be useful when the patient agrees, but they should not replace the person’s account or a professional assessment. The aim is to give the team enough information to recommend an appropriate pathway.

Drug treatment may be outpatient, more intensive, or residential depending on the substances and circumstances. A useful assessment considers whether the person can attend reliably, what support is available, and whether the home environment helps or obstructs engagement. A residential stay should have an individual rationale rather than being the automatic response to a cannabis treatment inquiry. [4]

For someone who can engage with local care, outpatient treatment can keep the work connected to ordinary routines. A residential setting may be considered when a more structured period away is appropriate. Ask what problem the residence is intended to solve and what skills or arrangements will support the eventual return. Time away does not remove the need to plan for familiar situations.

Stopping frequent cannabis use can involve sleep disturbance, irritability, anxiety, low mood, or appetite changes. These symptoms deserve assessment and support rather than dismissal. Their presence also does not tell you, by itself, which setting is required. The Royal College of Psychiatrists describes withdrawal and recommends professional help where needed. [5]

New hallucinations, severe confusion, or a marked loss of contact with reality need prompt medical assessment; an immediate safety crisis requires urgent care. Do not interpret severe psychiatric symptoms as routine discomfort to manage within an unassessed residential booking. Cannabis-related mental health needs and the residence’s actual medical scope should be reviewed before travel. [5] [6]

Other substances can change the picture. If alcohol or prescribed sedatives create withdrawal risk, a separate medical plan may be necessary. COGNIFUL may require care elsewhere before admission. A cannabis-focused stay should not imply that every associated substance or acute condition can be managed in the same residence. [6]

These services are not equivalent residential purchases. A university clinic may offer a useful specialist assessment while having no luxury accommodation. A private residence may provide individual work and a comfortable stay while having a different medical scope. Ask about the actual treatment pathway instead of assuming that price determines clinical capability.

International eligibility deserves a separate check. A local or catchment-based service may not be available to a visitor on the same terms as a resident. An international private program may still determine that the person needs another level of care. Both access and suitability must be established before arranging travel.

Motivation and goals

WHO guidance identifies motivational enhancement, cognitive behavioral therapy, and family approaches as options that may be offered for cannabis dependence. It rates that recommendation as conditional with low-quality evidence. The practical implication is to ask about an appropriate method, realistic goals, and review, without treating any technique as a guaranteed cure. [10]

A useful program should help the person clarify what they want to change and why. Ambivalence can be discussed rather than treated as proof that help is pointless. Ask how the clinician works with differences between the patient’s goals and the family’s expectations. A plan is more understandable when the person can explain its purpose in their own words.

Goals should be specific enough to review. They may involve changes in use, improved engagement with treatment, daily functioning, or a different response to situations associated with cannabis. The treating professional should guide the clinical recommendations. The admissions conversation should make clear that the individual plan will be developed through assessment rather than decided by a generic package name.

Skills and daily routines

Ask what cognitive behavioral work will involve in practice. Will sessions examine the situations, thoughts, and responses linked to use? How will the person practice a different response? What happens when a strategy does not help? The method should be described clearly enough to distinguish clinical work from a schedule of activities that mainly fills time.

For example, someone who uses cannabis every evening may need to examine what that period of the day contains: fatigue, isolation, unstructured time, or another experience. This is an illustration of a treatment question, not an assumption about every client. The relevant plan should be based on the individual’s pattern and developed with the clinician.

Ask how sleep is evaluated when cannabis has become part of the bedtime routine. A program should consider the underlying sleep concern and changes associated with reducing use, rather than imply that a new residence automatically resolves both. Any medication discussion requires an appropriate professional and a plan for monitoring and later care.

Mental health and family involvement

Cannabis use and mental health can interact, and some people need support for both. The Royal College of Psychiatrists advises seeking professional help for mental health symptoms and prompt assessment for possible psychosis. Ask how the program coordinates these needs and when it would recommend a different setting. [5]

If family work is included, define its purpose and consent boundaries. It may help with communication or planning, but relatives should not be expected to become treatment staff. Ask who participates, what information is shared, and how the patient’s preferences are considered. Financial support from family does not, by itself, settle those clinical questions.

When several clinicians are involved, ask who holds the overall plan. A shared understanding is more useful than parallel appointments with no coordination. COGNIFUL describes consideration of co-occurring needs, but the actual professionals and services should be agreed for the individual case. [11] [12]

COGNIFUL offers a named cannabis addiction pathway within its Mallorca residential program and is part of THE BALANCE GROUP. Admission depends on clinical suitability and availability. Ask whether the person’s cannabis pattern, mental health needs, and other substances fit the proposed setting. Acute medical or psychiatric needs may require another service first; the residence should not be represented as a hospital. [1] [6]

Both program tiers accommodate a maximum of four clients at any time, with a private suite for each person. Clinical and bodywork sessions are individual. The residence, chef, and personal manager are shared in both programs. Other holistic sessions, excursions, and activities are shared in Premier; every session and activity is individual in Premier Plus. This describes a small shared residence, not exclusive occupancy. The client number does not establish a staffing ratio, a fixed therapy dose, or comparative effectiveness. [2]

COGNIFUL Premier and Premier Plus both include assessment, a personal plan, and continuing-care planning. Plus adds individual therapeutic work, family and transition work, and three months of aftercare. Further follow-up for the base program is agreed individually. Typical stays are four to twelve weeks, subject to review rather than a cannabis recovery timetable. [13] [14] View program fees

Request a cannabis-specific proposal naming the methods, professionals, and expected reviews. THE BALANCE GROUP’s shared clinical team does not imply that every listed professional participates in every stay. WHO’s discussion of psychological options should inform questions; it is not proof that each intervention appears in every COGNIFUL plan. Confirm the actual work rather than infer it from broad personalized-care language. [15] [12]

COGNIFUL operates on a self-pay basis and does not directly bill insurers. Ask for written fees, duration assumptions, inclusions, and exclusions. International clients should also agree receiving care at home, medication responsibilities where relevant, and the practical scope of aftercare. A planned online contact does not establish unrestricted cross-border clinical practice or replace every local appointment. [13] [14] [16]

Keep a realistic domestic option in the comparison. Ask what treatment abroad adds and what new responsibilities it creates. Distance may change the immediate environment, but the person still needs skills, support, and a plan for returning to familiar routines. A destination is more persuasive when the entire pathway can be explained.

Confirm the language of clinical work, consent, family sessions, and discharge information. A multilingual admissions conversation does not establish that all relevant professionals use the same language. If the receiving team at home needs documents in another language, agree how that will be handled before the stay ends.

Discuss the practical demands of treatment. Which work or caregiving responsibilities need to be delegated? How much outside communication fits with the proposed schedule? What does family participation require? These are questions about making treatment usable, not promises that every obligation can continue unchanged during residence.

Identify a receiving clinician or service and arrange consent-based communication. Ask who sends the summary, what information it contains, and who books the first follow-up. A document alone is not a handoff unless the receiving professional has agreed to take responsibility for the next stage. [16]

Review the first week at home in concrete terms. What happens during the evening or social situation previously linked to use? Which appointments are confirmed? Who can help if distress or use increases? The plan should offer accessible next steps rather than assume the person can reproduce the atmosphere of a residence indefinitely.

Compare costs across the full proposed episode. Ask about clinical assessment, any external services, the stay, and follow-up. Confirm what is included rather than assuming that a premium rate covers everything. If providers recommend different durations, ask what clinical needs explain the difference and how progress will be reviewed.

Ask how the team will discuss progress during the stay. Attendance alone does not show whether the work is becoming useful outside sessions. A review can consider the agreed goals, changes in the person’s experience, difficulties that remain, and the support needed for the next stage. The measures should be clinically appropriate and explained to the patient rather than presented as a mysterious score.

Privacy should be similarly concrete. Ask who can see records, who receives practical updates, and how requests from relatives, employers, or advisers are handled. A private suite still sits within an organization with staff, shared spaces, and administrative processes. Clear arrangements help the person participate comfortably without relying on an undefined promise of total anonymity.

Finally, ask what would lead the provider to recommend a different setting. A thoughtful answer identifies clinical boundaries and a process for reassessment. It should not imply that every difficulty can be solved by extending a stay or adding amenities. Knowing the limits of the proposed program is part of choosing a suitable treatment option, especially when the person will be far from established clinicians and support.

Does cannabis treatment always require residence?

No. The appropriate intensity depends on assessment and circumstances. Outpatient psychological treatment may be a workable option, while residence may be considered when a more structured setting is appropriate. Ask for the individual rationale. [4] [10]

Can cannabis withdrawal affect sleep and mood?

Yes. Sleep disruption, anxiety, irritability, low mood, and appetite changes can occur after stopping frequent use. Seek professional assessment when symptoms are concerning, and do not assume severe psychiatric symptoms are routine withdrawal. [5]

Does legal access mean treatment is unnecessary?

No. Clinical assessment concerns control, health, and daily functioning. The CDC’s description of cannabis use disorder focuses on those patterns and consequences, rather than making legal availability the test for whether someone needs help. [3]

How do I discuss a COGNIFUL stay?

Ask for a suitability review with accurate cannabis, medication, other substance, and mental health information. Request the proposed psychological work, written fees, and a home-country continuing-care plan before arranging travel. [16] [13]

1. Cannabis addiction treatment at COGNIFUL — COGNIFUL
2. Life at COGNIFUL in Mallorca — COGNIFUL
3. Understanding your risk for cannabis use disorder — Centers for Disease Control and Prevention
4. Drug addiction: getting help — NHS
5. Cannabis and mental health — Royal College of Psychiatrists
6. Clinical scope, suitability and care coordination — COGNIFUL
7. Cannabis treatment options — Jellinek
8. Addiction Psychiatry Clinic — UCLA Health
9. Addiction disorders and dual diagnoses — Psychiatric University Hospital Zurich
10. Psychosocial interventions for cannabis dependence — World Health Organization
11. Co-occurring mental health and addiction needs — COGNIFUL
12. How residential treatment works at COGNIFUL — COGNIFUL
13. COGNIFUL programs, fees and admissions — COGNIFUL
14. Reintegration and continuing care — COGNIFUL
15. Clinical team and care coordination — COGNIFUL
16. Professional referrals — COGNIFUL

Source information checked October 18, 2026. Confirm current services, eligibility, fees, and availability directly with each provider.